Literature DB >> 27196972

Understanding Dopaminergic Cell Death Pathways in Parkinson Disease.

Patrick P Michel1, Etienne C Hirsch2, Stéphane Hunot1.   

Abstract

Parkinson disease (PD) is a multifactorial neurodegenerative disorder, the etiology of which remains largely unknown. Progressive impairment of voluntary motor control, which represents the primary clinical feature of the disease, is caused by a loss of midbrain substantia nigra dopamine (DA) neurons. We present here a synthetic overview of cell-autonomous mechanisms that are likely to participate in DA cell death in both sporadic and inherited forms of the disease. In particular, we describe how damage to vulnerable DA neurons may arise from cellular disturbances produced by protein misfolding and aggregation, disruption of autophagic catabolism, endoplasmic reticulum (ER) stress, mitochondrial dysfunction, or loss of calcium homeostasis. Where pertinent, we show how these mechanisms may mutually cooperate to promote neuronal death.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27196972     DOI: 10.1016/j.neuron.2016.03.038

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  163 in total

Review 1.  Dopamine tunes prefrontal outputs to orchestrate aversive processing.

Authors:  Caitlin M Vander Weele; Cody A Siciliano; Kay M Tye
Journal:  Brain Res       Date:  2018-12-01       Impact factor: 3.252

Review 2.  Genetic predispositions of Parkinson's disease revealed in patient-derived brain cells.

Authors:  Jenne Tran; Helena Anastacio; Cedric Bardy
Journal:  NPJ Parkinsons Dis       Date:  2020-04-24

Review 3.  Mitochondrial dysfunction in protein conformational disorders.

Authors:  Shlomi Brielle; Daniel Kaganovich
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 4.  Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs.

Authors:  Delphine Charvin; Rossella Medori; Robert A Hauser; Olivier Rascol
Journal:  Nat Rev Drug Discov       Date:  2018-09-28       Impact factor: 84.694

Review 5.  Enteric nervous system manifestations of neurodegenerative disease.

Authors:  Alcmène Chalazonitis; Meenakshi Rao
Journal:  Brain Res       Date:  2018-01-31       Impact factor: 3.252

6.  Network Analysis Identifies Disease-Specific Pathways for Parkinson's Disease.

Authors:  Chiara Monti; Ilaria Colugnat; Leonardo Lopiano; Adriano Chiò; Tiziana Alberio
Journal:  Mol Neurobiol       Date:  2016-12-21       Impact factor: 5.590

Review 7.  Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Authors:  J A Obeso; M Stamelou; C G Goetz; W Poewe; A E Lang; D Weintraub; D Burn; G M Halliday; E Bezard; S Przedborski; S Lehericy; D J Brooks; J C Rothwell; M Hallett; M R DeLong; C Marras; C M Tanner; G W Ross; J W Langston; C Klein; V Bonifati; J Jankovic; A M Lozano; G Deuschl; H Bergman; E Tolosa; M Rodriguez-Violante; S Fahn; R B Postuma; D Berg; K Marek; D G Standaert; D J Surmeier; C W Olanow; J H Kordower; P Calabresi; A H V Schapira; A J Stoessl
Journal:  Mov Disord       Date:  2017-09       Impact factor: 10.338

8.  Role of the Axon Initial Segment in the Control of Spontaneous Frequency of Nigral Dopaminergic Neurons In Vivo.

Authors:  Rodrigo C Meza; Luciana López-Jury; Carmen C Canavier; Pablo Henny
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

Review 9.  In Silico and In Vivo Studies on Quercetin as Potential Anti-Parkinson Agent.

Authors:  Hemanth Kumar Boyina; Sree Lakshmi Geethakhrishnan; Swetha Panuganti; Kiran Gangarapu; Krishna Prasad Devarakonda; Vasudha Bakshi; Sandhya Rani Guggilla
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 10.  Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.

Authors:  Toshiharu Nagatsu; Ikuko Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  2016-08-04       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.